ArticleJAMA oncology2019

Potential Areas of Interest in a Trial of Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin for Hepatocellular Carcinoma-In Reply.

MinKe He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.